Lexagene Holdings Inc
XTSX:LXG

Watchlist Manager
Lexagene Holdings Inc Logo
Lexagene Holdings Inc
XTSX:LXG
Watchlist
Price: 0.105 CAD Market Closed
Market Cap: CA$14.8m

Relative Value

There is not enough data to reliably calculate the relative value of LXG.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LXG Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

LXG Competitors Multiples
Lexagene Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Lexagene Holdings Inc
XTSX:LXG
14.8m CAD 55 -0.6 -0.5 -0.5
US
Abbott Laboratories
NYSE:ABT
190.1B USD 4.3 29.1 16.5 22.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD 18 63.4 48.5 58.6
US
Stryker Corp
NYSE:SYK
140.5B USD 5.8 47.9 23.3 28.2
US
Boston Scientific Corp
NYSE:BSX
139.4B USD 7.2 49.9 29.2 39.8
IE
Medtronic PLC
NYSE:MDT
131.6B USD 3.8 27.6 15.5 22.4
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD 2.7 34.7 12.7 21.7
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR 2 22 12.6 17.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD 13 52.6 37.8 41.8
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD 8.1 34.7 24.7 27.1
US
Resmed Inc
NYSE:RMD
37.1B USD 7.1 25.9 18.6 20.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Lexagene Holdings Inc
XTSX:LXG
Average EV/EBITDA: 23.9
Negative Multiple: -0.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
48.5
24%
2
US
Stryker Corp
NYSE:SYK
23.3
13%
1.8
US
Boston Scientific Corp
NYSE:BSX
29.2
22%
1.3
IE
Medtronic PLC
NYSE:MDT
15.5
8%
1.9
US
Becton Dickinson and Co
NYSE:BDX
12.7
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.6
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.8
14%
2.7
US
Edwards Lifesciences Corp
NYSE:EW
24.7
13%
1.9
US
Resmed Inc
NYSE:RMD
18.6
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Lexagene Holdings Inc
XTSX:LXG
Average EV/EBIT: 30
Negative Multiple: -0.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.5
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.6
25%
2.3
US
Stryker Corp
NYSE:SYK
28.2
16%
1.8
US
Boston Scientific Corp
NYSE:BSX
39.8
32%
1.2
IE
Medtronic PLC
NYSE:MDT
22.4
17%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.7
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.7
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.8
15%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
27.1
14%
1.9
US
Resmed Inc
NYSE:RMD
20.6
12%
1.7